Budez CR (Budesonide) 3 mg Controlled-Release Capsules

Budez CR is a controlled-release oral capsule containing 3 mg of budesonide, a corticosteroid formulated to act mainly where Crohn's disease most often begins. We carry Budez CR in packs of 30, 60, 90, and 180 capsules so customers can match their order to the length of a prescribed course.

Budez CR Overview

Composition and Active Ingredient

Each Budez CR capsule supplies 3 mg of budesonide in a controlled-release formulation designed to resist breakdown in the stomach and upper small intestine. The formulation releases budesonide as it reaches the terminal ileum and ascending colon, delivering the medicine to tissue commonly affected by ileocecal Crohn's disease. Budesonide acts mainly locally after release, while absorbed medicine undergoes extensive first-pass metabolism in the liver. This generally produces lower systemic corticosteroid exposure than older steroids such as prednisone, although body-wide corticosteroid effects can still occur.

Established Uses

Budesonide capsules of this type are indicated for inducing remission in mild to moderate active Crohn's disease involving the ileum and/or ascending colon, and for maintaining that remission for up to three months in adults. Pediatric use is established for patients aged 8 to 17 years who weigh more than 25 kg, using age- and weight-appropriate dosing set by a prescriber. Because Budez CR concentrates its effect in a specific segment of the bowel, it is not interchangeable with corticosteroid formulations designed for ulcerative colitis or with medicines meant to act throughout the whole body.

Prescription Requirement

Budesonide is a corticosteroid, and treatment decisions, dosing, and monitoring are properly guided by a clinician familiar with a person's Crohn's disease history. Our checkout does not require a submitted prescription document to accept a Budez CR order, which lets customers who already have clinician guidance reorder efficiently; we still recommend confirming the diagnosis, dose, and duration with a prescriber before starting or renewing a course. Because the exact "Budez CR" product name has not been confirmed against current FDA-approved labeling, customers who want manufacturer-specific U.S. prescribing information should also check the labeling that applies to their exact capsule batch.

General Dosing and Warnings for Budez CR

How and When to Take Budez CR

For controlled-release budesonide 3 mg capsules used for active ileal or right-sided Crohn's disease, a common adult induction regimen is 9 mg, or three capsules, once daily in the morning for up to eight weeks. Adult maintenance after symptoms are controlled is commonly 6 mg once daily for up to three months, followed by a gradual reduction when directed. For patients aged 8 to 17 years who weigh more than 25 kg, established reference dosing is 9 mg once daily for up to eight weeks, followed by 6 mg once daily for two weeks. The exact regimen and any taper should follow the prescriber's directions and the product-specific leaflet. Swallow the capsules whole with water and do not crush or chew them; do not open them unless the instructions supplied with the exact product expressly permit this. They may generally be taken with or without food, but taking each dose consistently in the morning is advisable.

Missed Dose

If a dose of Budez CR is missed, it should be taken as soon as it is remembered on the same day. If it is close to the time of the next scheduled dose, the missed dose should be skipped rather than doubled up, and the regular one-a-day schedule should simply continue. Taking two doses together to make up for a missed one increases the amount of budesonide released at once without improving control of Crohn's disease symptoms.

Suspected Overdose

Taking more Budez CR than directed can increase systemic corticosteroid exposure, particularly when excess doses are taken repeatedly. Possible effects include swelling, mood changes, elevated blood sugar, adrenal suppression, or infection symptoms being masked. Anyone who has taken substantially more than directed, is unsure how much was taken, or develops concerning symptoms should contact Poison Control at 1-800-222-1222 in the United States or seek urgent medical care. Keep the capsule packaging available so the exact strength and quantity can be identified.

Precautions Before Using Budez CR

Allergy Warnings

Budez CR should not be used by anyone with a known hypersensitivity to budesonide or to any inactive ingredient in the capsule shell or coating. Signs of an allergic reaction can include rash, itching, swelling of the face or throat, or difficulty breathing, and any of these call for stopping the medicine and seeking prompt medical care. Aside from this direct hypersensitivity, budesonide does not carry a broader medicine-class cross-reactivity warning that would concern most people with unrelated allergies.

Health Condition Warnings

Because budesonide is a corticosteroid, it calls for caution in several situations even though its systemic exposure is generally lower than older steroids. People with diabetes should monitor blood glucose closely, since corticosteroids that reach the bloodstream can raise blood sugar and blunt glycemic control. Liver impairment can slow the metabolism that normally limits budesonide's systemic effects, so people with significant liver disease need individualized dosing. Active or recent infections, including tuberculosis, chickenpox, or measles exposure, deserve discussion with a prescriber before starting treatment, since corticosteroids can mask or worsen infection. Pregnancy and breastfeeding both call for a benefit-versus-risk discussion with a clinician: animal studies have shown corticosteroid effects on the developing fetus, newborns exposed in utero can have reduced adrenal function, and budesonide can pass into breast milk, so individualized monitoring is appropriate rather than routine use in either situation. Pediatric use below age 8 or in children weighing 25 kg or less has not been established. People taking Budez CR long-term should also have periodic monitoring of bone density, blood pressure, and eye health, reflecting standard corticosteroid precautions.

Budez CR Side Effects

Because Budez CR concentrates its effect in the bowel, its side-effect profile tends to be milder than that of systemic corticosteroids, though it is not free of typical steroid-related effects. Commonly reported effects include headache, nausea, indigestion, respiratory infection symptoms, back pain, and mild swelling. Some people notice acne, changes in mood, or minor weight gain during a treatment course. Effects that call for prompt medical attention include signs of adrenal insufficiency after stopping treatment, such as fatigue, dizziness, or low blood pressure; visual disturbances that could indicate elevated eye pressure or cataract; unusual bruising; significant mood or behavioral changes; or symptoms of a serious infection, since corticosteroids can blunt the usual warning signs. Long-term or high-dose use raises the chance of more systemic corticosteroid effects, including bone thinning, so any unusual or persistent symptom during treatment is worth discussing with a prescriber rather than waiting it out.

Budez CR Medicine Interactions

Budesonide is broken down mainly by a liver enzyme pathway called CYP3A4, so medicines that strongly inhibit that pathway, including ketoconazole, itraconazole, clarithromycin, and certain HIV protease inhibitors, can raise budesonide levels and increase the risk of systemic corticosteroid effects; these combinations are generally avoided or require medical supervision. Grapefruit juice affects the same pathway and can meaningfully increase budesonide exposure, so it is best avoided during treatment. Other corticosteroids taken at the same time, whether oral, inhaled, or topical, can add to overall steroid exposure and should be reviewed with a prescriber. Live vaccines are generally avoided when a person is receiving an immunosuppressive corticosteroid dose, and responses to other vaccines may be reduced. Cholestyramine and similar bile acid-binding agents may interfere with budesonide absorption, so a pharmacist or prescriber should advise whether the doses need to be separated. Anyone taking other prescription or over-the-counter medicines, herbal products, or recent vaccines should mention them to a pharmacist or prescriber before starting Budez CR.

After Using Budez CR

Storage

Budez CR capsules should be stored below 77°F, kept away from direct light and moisture, and left in their original, tightly closed container rather than transferred to a pillbox exposed to humidity. A bathroom cabinet is often too humid for reliable storage; a bedroom drawer or a kitchen cabinet away from the stove or sink tends to work better. Capsules should be kept out of reach of children and pets given their corticosteroid content.

Disposal

A medicine take-back program or authorized collection site is the preferred way to dispose of leftover or expired Budez CR capsules. Do not flush them unless the product-specific instructions expressly say to do so. If no take-back option is readily available, mix the capsules without crushing them with an unappealing substance such as used coffee grounds, place the mixture in a sealed bag or container, and put it in the household trash. Remove or obscure personal information on the original packaging before discarding it, and keep the medicine inaccessible to children and pets throughout disposal.

Alternatives to Budez CR Capsules

Several other budesonide-based capsules use a similar controlled-release approach for ileal and ascending-colon Crohn's disease, including Entocort EC and Budenofalk, both of which deliver the same active ingredient in comparable capsule form; a switch between these products is a decision for a prescriber rather than an interchangeable substitution. Extended-release budesonide tablets such as Cortiment and Uceris are formulated differently, releasing along the colon for ulcerative colitis rather than targeting the ileum for Crohn's disease, so they serve a distinct clinical purpose despite sharing the same active ingredient. For people who need a broader-acting corticosteroid, oral prednisone or Prednisolone tablets act throughout the body rather than mainly in the bowel, which can increase systemic corticosteroid effects. Mesalamine-based products, including Pentasa and Asacol, use a different, non-steroidal anti-inflammatory mechanism and are used mainly for ulcerative colitis; they are not direct substitutes for controlled-release budesonide in ileal or right-sided Crohn's disease. Anyone weighing these alternatives can also review our broader selection of gastrointestinal treatments to compare active ingredients and forms before discussing a change with a prescriber.